D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 34,880 494 World Ranking 6083 National Ranking 3344

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Atrial fibrillation

Jonathan P. Piccini mostly deals with Atrial fibrillation, Internal medicine, Stroke, Cardiology and Warfarin. The various areas that Jonathan P. Piccini examines in his Atrial fibrillation study include Prospective cohort study, Heart failure, Embolism and Intensive care medicine. Jonathan P. Piccini focuses mostly in the field of Internal medicine, narrowing it down to matters related to Surgery and, in some cases, Radiology.

His Stroke research includes elements of Risk assessment, Rivaroxaban, Gastrointestinal bleeding and Clinical endpoint. His study in Rivaroxaban is interdisciplinary in nature, drawing from both Gastroenterology, Anesthesia, Framingham Risk Score and Renal function. His Warfarin study incorporates themes from Anticoagulant, Quartile and Incidence.

His most cited work include:

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (6202 citations)
  • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment (477 citations)
  • Arrhythmogenic Right Ventricular Dysplasia A United States Experience (376 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Atrial fibrillation, Cardiology, Stroke and Heart failure are his primary areas of study. His work in the fields of Internal medicine, such as Hazard ratio, Myocardial infarction, Proportional hazards model and Ablation, intersects with other areas such as In patient. His Atrial fibrillation study combines topics from a wide range of disciplines, such as Embolism and Intensive care medicine.

Jonathan P. Piccini combines subjects such as Interquartile range and Clinical trial with his study of Cardiology. The concepts of his Stroke study are interwoven with issues in Prospective cohort study, Randomized controlled trial, Surgery, Lower risk and Cohort. His Warfarin research integrates issues from Anticoagulant, Anesthesia and Renal function.

He most often published in these fields:

  • Internal medicine (90.38%)
  • Atrial fibrillation (84.99%)
  • Cardiology (75.36%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (90.38%)
  • Atrial fibrillation (84.99%)
  • Cardiology (75.36%)

In recent papers he was focusing on the following fields of study:

Jonathan P. Piccini spends much of his time researching Internal medicine, Atrial fibrillation, Cardiology, Catheter ablation and Heart failure. His study in Internal medicine focuses on Cohort, Proportional hazards model, Ventricular tachycardia, Confidence interval and Hazard ratio. In the subject of general Atrial fibrillation, his work in Warfarin is often linked to In patient, thereby combining diverse domains of study.

His study in Catheter ablation is interdisciplinary in nature, drawing from both Cardiomyopathy, Emergency department and Left atrial. His research investigates the link between Heart failure and topics such as Clinical trial that cross with problems in Medical physics. In his study, which falls under the umbrella issue of Stroke, Obstructive sleep apnea is strongly linked to Myocardial infarction.

Between 2019 and 2021, his most popular works were:

  • Atrioventricular synchronous pacing using a leadless ventricular pacemaker: Results from the MARVEL 2 study (44 citations)
  • Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19. (15 citations)
  • Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice (12 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cardiology

The scientist’s investigation covers issues in Atrial fibrillation, Internal medicine, Cardiology, Heart failure and Catheter ablation. The Atrial fibrillation study combines topics in areas such as Stroke, mHealth, Quality of life and Heart Rhythm. His study looks at the relationship between Stroke and topics such as Myocardial infarction, which overlap with Obstructive sleep apnea and Risk factor.

His work in the fields of Cardiology, such as Ventricular pacemaker, Cardiac tamponade and Myocardial perfusion imaging, overlaps with other areas such as Clinical Practice. His research in Heart failure intersects with topics in University hospital, Clinical trial, Clinical course and Intensive care medicine. His Cohort research incorporates elements of Hazard ratio and Confidence interval.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan.
The New England Journal of Medicine (2011)

9360 Citations

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

Keith A. A. Fox;Jonathan P. Piccini;Daniel Wojdyla;Richard C. Becker.
European Heart Journal (2011)

727 Citations

Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

Jonathan P. Piccini;Susanna R. Stevens;YuChiao Chang;Daniel E. Singer.
Circulation (2013)

556 Citations

Arrhythmogenic Right Ventricular Dysplasia A United States Experience

Darshan Dalal;Khurram Nasir;Chandra Bomma;Kalpana Prakasa.
Circulation (2005)

551 Citations

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Douglas L. Packer;Daniel B. Mark;Richard A. Robb;Kristi H. Monahan.
JAMA (2019)

532 Citations

Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

Jonathan P. Piccini;Bradley G. Hammill;Moritz F. Sinner;Paul N. Jensen.
Circulation-cardiovascular Quality and Outcomes (2012)

459 Citations

Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials

Jonathan P. Piccini;Renato D. Lopes;Melissa H. Kong;Vic Hasselblad.
Circulation-arrhythmia and Electrophysiology (2009)

384 Citations

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Jonathan L. Halperin;Graeme J. Hankey;Daniel M. Wojdyla;Jonathan P. Piccini.
Circulation (2014)

377 Citations

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

Ben Freedman;John Camm;Hugh Calkins;Jeffrey S Healey.
Circulation (2017)

346 Citations

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Jonathan P. Piccini;Susanna R. Stevens;Yuliya Lokhnygina;Manesh R. Patel.
Journal of the American College of Cardiology (2013)

342 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jonathan P. Piccini

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 845

Paulus Kirchhof

Paulus Kirchhof

University of Birmingham

Publications: 151

Hugh Calkins

Hugh Calkins

Johns Hopkins University

Publications: 137

John W. Eikelboom

John W. Eikelboom

Population Health Research Institute

Publications: 128

Renato D. Lopes

Renato D. Lopes

Duke University

Publications: 113

Christopher B. Granger

Christopher B. Granger

Duke University

Publications: 113

Giuseppe Boriani

Giuseppe Boriani

University of Modena and Reggio Emilia

Publications: 109

A. John Camm

A. John Camm

St George's Hospital

Publications: 109

Deirdre A. Lane

Deirdre A. Lane

University of Liverpool

Publications: 105

Jeff S. Healey

Jeff S. Healey

Population Health Research Institute

Publications: 99

Stuart J. Connolly

Stuart J. Connolly

Population Health Research Institute

Publications: 98

Shih-Ann Chen

Shih-Ann Chen

Taipei Veterans General Hospital

Publications: 93

Lars Wallentin

Lars Wallentin

Uppsala University

Publications: 89

Robert P. Giugliano

Robert P. Giugliano

Brigham and Women's Hospital

Publications: 89

Andrea Natale

Andrea Natale

Case Western Reserve University

Publications: 88

Gunnar H. Gislason

Gunnar H. Gislason

National Heart Foundation of Australia

Publications: 85

Something went wrong. Please try again later.